Loading clinical trials...
Loading clinical trials...
A Randomized, Prospective, Multicenter, Double-Blind, Sham-Controlled Study to Assess the MORPHEUSV Radiofrequency (RF) Device in the Treatment of Female Patients With Idiopathic Overactive Bladder (OAB) With Urge Incontinence and/or Urge-Predominant Mixed Incontinence
Conditions
Interventions
Detrusor nerve radiofrequency ablation
Simulated (sham) detrusor nerve radiofrequency ablation
Locations
9
United States
Stanford Medicine Department of Obstetrics & Gynecology
Palo Alto, California, United States
MedStar Health Research Institute
Washington D.C., District of Columbia, United States
Advanced Specialty Research
Boise, Idaho, United States
University of Chicago Medicine Urogynecology
Chicago, Illinois, United States
Cypress Medical Research Center
Wichita, Kansas, United States
Bay State Clinical Trials
Watertown, Massachusetts, United States
Start Date
November 25, 2025
Primary Completion Date
June 30, 2027
Completion Date
November 30, 2027
Last Updated
January 30, 2026
NCT06789406
NCT05362292
NCT07193407
NCT07195656
NCT05799313
NCT04873037
Lead Sponsor
InMode MD Ltd.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions